Brief: Apyx Medical Reports Q4, Full Year 2021 Financial Results
March 17 (Reuters) - Apyx Medical Corp APYX.O :
* ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS; INTRODUCES FULL YEAR 2022 FINANCIAL OUTLOOK
* Q4 REVENUE ROSE 47 PERCENT TO $16.8 MILLION
* SEES FY REVENUE UP 3 TO 30 PERCENT
* SEES FY REVENUE $50 MILLION TO $63 MILLION
* QTRLY LOSS PER SHARE $0.06
* Q4 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $14.6
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $59.9 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwbhfd1Fa
Further company coverage: APYX.O
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength